EP Wealth Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$458K Sell
21,409
-655
-3% -$13.6K ﹤0.01% 937
2025
Q4
$472K Buy
+22,064
New +$452K ﹤0.01% 907
2025
Q2
$324K Buy
22,579
+1,180
+6% +$16.2K ﹤0.01% 974
2025
Q1
$310K Buy
+21,399
New +$304K ﹤0.01% 899

Other funds holding MD

EP Wealth Advisors's MD Position: Q1 2026 in Review

EP Wealth Advisors reduced its Pediatrix Medical (MD) stake by 3% in Q1 2026, selling an estimated $13.6K and leaving 21,409 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #937.

EP Wealth Advisors first reported a position in MD in Q1 2025 and has held it in 4 quarters since. The position peaked at $472K in Q4 2025. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • EP Wealth Advisors held 21,409 shares of Pediatrix Medical worth $458K as of Q1 2026.
  • EP Wealth Advisors sold 655 Pediatrix Medical shares in Q1 2026, an estimated $13.6K.
  • Pediatrix Medical made up ﹤0.01% of EP Wealth Advisors's portfolio in Q1 2026, its #937 holding.
  • EP Wealth Advisors first reported a position in Pediatrix Medical in Q1 2025 and has held it in 4 quarters since.
  • EP Wealth Advisors's Pediatrix Medical position peaked at $472K in Q4 2025.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on EP Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.